MELD Score: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(19 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}; '''Associate Editor-In-Chief''': [[User:Suvekchha Devkota|Suvekchha Devkota]].
{{CMG}}; '''Associate Editor-In-Chief''': [[User:Suvekchha Devkota|Suvekchha Devkota]] ; [[User: Shankar Kumar |Shankar Kumar, M.B.B.S.]] [mailto:kumarshankar@wikidoc.org]]


==Overview==
==Overview==
The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a disease severity index to help prioritize allocation of organs for transplant.<ref>www.mayoclinic.org</ref>. The new system, known as the Model for End-Stage Liver Disease (MELD) score, leaves no room for subjective criteria favoritism or hospital-shopping, as it is based on a mathematical equation. The equation seeks to calculate a patient’s likelihood of dying within three months from their liver disease. In other words under the MELD scoring system - the sickest patient gets the liver transplant.
The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a disease severity index to help prioritize allocation of organs for transplant. The new system, known as the Model for End-Stage Liver Disease (MELD) score, leaves no room for subjective criteria favoritism or hospital-shopping, as it is based on a mathematical equation. The equation seeks to calculate a patient’s likelihood of dying within three months from their liver disease. In other words under the MELD scoring system - the sickest patient gets the liver transplant. It is more recent than the [[Child-Pugh score]].


==Historical Perspective==
==Historical Perspective==
This model was derived from a heterogeneous group of patients at 4 medical centers in the United States and validated in an independent data set from the Netherlands.<ref name="pmid11172350">{{cite journal| author=Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al.| title=A model to predict survival in patients with end-stage liver disease. | journal=Hepatology | year= 2001 | volume= 33 | issue= 2 | pages= 464-70 | pmid=11172350 | doi=10.1053/jhep.2001.22172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11172350  }} </ref>
This model was derived from a heterogeneous group of patients at 4 medical centers in the United States and validated in an independent data set from the Netherlands.<ref name="pmid11172350">{{cite journal| author=Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al.| title=A model to predict survival in patients with end-stage liver disease. | journal=Hepatology | year= 2001 | volume= 33 | issue= 2 | pages= 464-70 | pmid=11172350 | doi=10.1053/jhep.2001.22172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11172350  }} </ref>
The original version of the MELD scale as developed by investigators at Mayo Clinic. A number of modification have been made by UNOS (United Network for Organ Sharing) to the model for its implementation in organ allocation for liver transplantation. The Model for End-Stage Liver Disease (MELD) score has been used by the Organ Procurement and Transplantation Network (OPTN) since February 2002 as the basis for allocation of deceased donor livers for transplantation among adults in the United States.<ref name="pmid19033587">{{cite journal| author=Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ| title=Disparities in liver transplantation before and after introduction of the MELD score. | journal=JAMA | year= 2008 | volume= 300 | issue= 20 | pages= 2371-8 | pmid=19033587 | doi=10.1001/jama.2008.720 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19033587  }} </ref>
The original version of the MELD scale as developed by investigators at Mayo Clinic. It was initially described by Kamath et al in 2001 and modified by Wiesner et al, also in 2001.  A number of modification have been made by UNOS (United Network for Organ Sharing) to the model for its implementation in organ allocation for liver transplantation. The Model for End-Stage Liver Disease (MELD) score has been used by the Organ Procurement and Transplantation Network (OPTN) since February 2002 as the basis for allocation of deceased donor livers for transplantation among adults in the United States.<ref name="pmid19033587">{{cite journal| author=Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ| title=Disparities in liver transplantation before and after introduction of the MELD score. | journal=JAMA | year= 2008 | volume= 300 | issue= 20 | pages= 2371-8 | pmid=19033587 | doi=10.1001/jama.2008.720 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19033587  }} </ref>


==Calculation of MELD Score==
==Calculation of MELD Score==
The MELD Calculator is a utility that allows you to enter hypothetical or actual parameters and calculate a MELD score for an individual patient. The MELD/PELD Calculator uses the specific formulas approved by the OPTN/UNOS Board of Directors and used for the allocation of livers by the OPTN match system. The MELD score calculation uses-
The MELD Calculator is a utility that allows you to enter hypothetical or actual parameters and calculate a MELD score for an individual patient. The MELD/PELD Calculator uses the specific formulas approved by the OPTN/UNOS Board of Directors and used for the allocation of livers by the OPTN match system. The MELD score calculation uses-
*Serum Creatinine (mg/dl) *
* [[Serum creatinine]] (mg/dl) *
*Bilirubin (mg/dl)
* [[Bilirubin]] (mg/dl)
*INR
* [[INR]]
For candidates on dialysis, defined as having 2 or more dialysis treatments within the prior week; or candidates who have received 24 hours of CVVHD within the prior week, will have their serum creatinine level automatically set to 4.0 mg/dl. The MELD Calculator is used for candidates who are 12 years and older.
For candidates on dialysis, defined as having 2 or more dialysis treatments within the prior week; or candidates who have received 24 hours of CVVHD (Continuous Veno-venous Hemodialysis) within the prior week, will have their serum creatinine level automatically set to 4.0 mg/dl. The MELD Calculator is used for candidates who are 12 years and older.


==MELD Formula==
==MELD Formula==
The MELD (Model for End Stage Liver Disease) is a more objective prognostic score, requiring however a calculation software.<ref>{{cite journal |author=Gex L, Bernard C, Spahr L |title=[Child-Pugh, MELD and Maddrey scores] |language=French |journal=Rev Med Suisse |volume=6 |issue=264 |pages=1803–4, 1806–8 |year=2010 |month=September |pmid=20964016 |doi= |url=}}</ref> The MELD score is calculated using the following formula
The MELD (Model for End Stage Liver Disease) is a more objective prognostic score, requiring however a calculation software. <ref>{{cite journal |author=Gex L, Bernard C, Spahr L |title=[Child-Pugh, MELD and Maddrey scores] |language=French |journal=Rev Med Suisse |volume=6 |issue=264 |pages=1803–4, 1806–8 |year=2010 |month=September |pmid=20964016 |doi= |url=}}</ref> The MELD score is calculated using the following formula
*MELD Score = 0.957 x Loge(creatinine mg/dL) + 0.378 x Loge(bilirubin mg/dL) + 1.120 x Loge(INR)+ 0.6431 Multiply the score by 10 and round to the nearest whole number. Laboratory values less than 1.0 are set to 1.0 for the purposes of the MELD score calculation.
* '''MELD Score = 0.957 x Loge(creatinine mg/dL) + 0.378 x Loge(bilirubin mg/dL) + 1.120 x Loge(INR)+ 0.6431'''
Multiply the score by 10 and round to the nearest whole number. Laboratory values less than 1.0 are set to 1.0 for the purposes of the MELD score calculation.
or '''MELD score= 3.8[Ln serum bilirubin (mg/dL)] + 11.2[Ln INR] + 9.6[Ln serum creatinine (mg/dL)] + 6.4'''
Caveats with the score include:
* The maximum score given for MELD is 40.  All values higher than 40 are given a score of 40
* If the patient has been dialyzed twice within the last 7 days, then the value for serum creatinine used should be 4.0
* Any value less than one is given a value of 1 (i.e. if bilirubin is 0.8, a value of 1.0 is used).


===Mortality Outcome===
===Mortality Outcome===
Line 28: Line 34:
*10–19 — 6.0% mortality
*10–19 — 6.0% mortality
*<9 — 1.9% mortality
*<9 — 1.9% mortality
==The MELD caclulators==
A variety of calculators which are specific to a particular clinical scenerio are as follows --
* The above mentioned UNOS MELD score has laboratory values of INR, total bilirubin and serum creatinine that are <1.0 are set to 1.0. It is used while setting priority for allocating deceased donor organs for liver transplantation.[http://www.mayoclinic.org/meld/mayomodel6.html]
*The first MELD score does not use upper or lower limits for laboratory values. Hence, they could have negative values to positive infinity. These are not used for allocation purposes while considering liver transplantation.[http://www.mayoclinic.org/meld/mayomodel5.html]
*A MELD score calculator to predict 90-day mortality in patients with alcoholic hepatitis [http://www.mayoclinic.org/meld/mayomodel7.html]
*A MELD score calculator for predicting postoperative mortality risk in patients with cirrhosis. This calculator is based upon the first published MELD score, thus the etiology of liver disease is required for the calculation [http://www.mayoclinic.org/meld/mayomodel7.html]
*A MELD-Na calculator, which incorporates serum sodium into the model [http://www.mayoclinic.org/meld/mayomodel8.html]
==Comparing Child-Pugh and MELD score==
The limitations of [[Child-Pugh score]] are as follows-
* Its based on subjective parameters like ascites and encephalopathy. Not only do these criterias vary with observers but also they may be affected by interventions like diuretics etc.
* It has a "ceiling and floor" effect. Example- a serum albumin value of 2.8 versus 1.5 will be highly varied clinically but it is rewarded the same point on Child-Pugh.
* Laboratory to laboratory variations in albumin and prothrombin values.<ref name="pmid11172350">{{cite journal |author=Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR |title=A model to predict survival in patients with end-stage liver disease |journal=[[Hepatology (Baltimore, Md.)]] |volume=33 |issue=2 |pages=464–70 |year=2001 |month=February |pmid=11172350 |doi=10.1053/jhep.2001.22172 |url=http://dx.doi.org/10.1053/jhep.2001.22172 |accessdate=2012-09-07}}</ref>
The points where MELD definitely edges over [[Child-Pugh score]] are-
* It relies on few, readily available, objective variables.
* Applicable to diverse set of patients with liver disease.
* Identifies and distinguishes the various points of severity along the disease spectrum.
The points where MELD lags behind are -
*Like [[Child-Pugh score]], it is not immune to laboratory variations in INR and creatinine values.<ref name="pmid15390325">{{cite journal |author=Trotter JF, Brimhall B, Arjal R, Phillips C |title=Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation |journal=[[Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society]] |volume=10 |issue=8 |pages=995–1000 |year=2004 |month=August |pmid=15390325 |doi=10.1002/lt.20195 |url=http://dx.doi.org/10.1002/lt.20195 |accessdate=2012-09-07}}</ref><ref name="pmid17659574">{{cite journal |author=Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'Era A, Sei C, Mannucci PM |title=The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation |journal=[[Hepatology (Baltimore, Md.)]] |volume=46 |issue=2 |pages=520–7 |year=2007 |month=August |pmid=17659574 |doi=10.1002/hep.21732 |url=http://dx.doi.org/10.1002/hep.21732 |accessdate=2012-09-07}}</ref><ref name="pmid17654598">{{cite journal |author=Bellest L, Eschwège V, Poupon R, Chazouillères O, Robert A |title=A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology |journal=[[Hepatology (Baltimore, Md.)]] |volume=46 |issue=2 |pages=528–34 |year=2007 |month=August |pmid=17654598 |doi=10.1002/hep.21680 |url=http://dx.doi.org/10.1002/hep.21680 |accessdate=2012-09-07}}</ref><ref name="pmid17323365">{{cite journal |author=Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK |title=Different methods of creatinine measurement significantly affect MELD scores |journal=[[Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society]] |volume=13 |issue=4 |pages=523–9 |year=2007 |month=April |pmid=17323365 |doi=10.1002/lt.20994 |url=http://dx.doi.org/10.1002/lt.20994 |accessdate=2012-09-07}}</ref><ref name="pmid15737021">{{cite journal |author=Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L |title=Creatinine measurement: state of the art in accuracy and interlaboratory harmonization |journal=[[Archives of Pathology & Laboratory Medicine]] |volume=129 |issue=3 |pages=297–304 |year=2005 |month=March |pmid=15737021 |doi=10.1043/1543-2165(2005)129<297:CMSOTA>2.0.CO;2 |url=http://www.archivesofpathology.org/doi/full/10.1043/1543-2165(2005)129<297:CMSOTA>2.0.CO;2 |accessdate=2012-09-07}}</ref>
Studies have compared the accuracy of MELD versus the Child-Pugh score for predicting the survival of patients on liver transplant waiting list have shown an equivalence but not superiority. <ref name="pmid16799946">{{cite journal |author=Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK |title=A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation |journal=[[Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society]] |volume=12 |issue=7 |pages=1049–61 |year=2006 |month=July |pmid=16799946 |doi=10.1002/lt.20824 |url=http://dx.doi.org/10.1002/lt.20824 |accessdate=2012-09-07}}</ref>The objective criteria used in the MELD score have led to widespread adoption of MELD as an accurate mortality predictor in patients awaiting liver transplantation.
==Improving MELD score==
The proposed modifications that are on way for MELD score are as follows--
*MELDNa  — Serum sodium levels decrease in cirrhotic patients. One school of thought suggests that in the setting of hyponatremia, it would be advisable to include serum sodium levels in the MELD model. Improvement in accuracy of the MELD score has been noted in studies.<ref name="pmid16697729">{{cite journal |author=Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G |title=Evidence-based incorporation of serum sodium concentration into MELD |journal=[[Gastroenterology]] |volume=130 |issue=6 |pages=1652–60 |year=2006 |month=May |pmid=16697729 |doi=10.1053/j.gastro.2006.02.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0016-5085(06)00272-1 |accessdate=2012-09-07}}</ref><ref name="pmid17452425">{{cite journal |author=Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P |title=MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation |journal=[[Gut]] |volume=56 |issue=9 |pages=1283–90 |year=2007 |month=September |pmid=17452425 |pmc=1954951 |doi=10.1136/gut.2006.102764 |url=http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=17452425 |accessdate=2012-09-07}}</ref><ref name="pmid17663415">{{cite journal |author=Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J |title=An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis |journal=[[Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society]] |volume=13 |issue=8 |pages=1174–80 |year=2007 |month=August |pmid=17663415 |doi=10.1002/lt.21197 |url=http://dx.doi.org/10.1002/lt.21197 |accessdate=2012-09-07}}</ref><ref name="pmid15382176">{{cite journal |author=Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA |title=Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death |journal=[[Hepatology (Baltimore, Md.)]] |volume=40 |issue=4 |pages=802–10 |year=2004 |month=October |pmid=15382176 |doi=10.1002/hep.20405 |url=http://dx.doi.org/10.1002/hep.20405 |accessdate=2012-09-07}}</ref><ref name="pmid15719386">{{cite journal |author=Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG |title=Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone |journal=[[Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society]] |volume=11 |issue=3 |pages=336–43 |year=2005 |month=March |pmid=15719386 |doi=10.1002/lt.20329 |url=http://dx.doi.org/10.1002/lt.20329 |accessdate=2012-09-07}}</ref><ref name="pmid18768945">{{cite journal |author=Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM |title=Hyponatremia and mortality among patients on the liver-transplant waiting list |journal=[[The New England Journal of Medicine]] |volume=359 |issue=10 |pages=1018–26 |year=2008 |month=September |pmid=18768945 |doi=10.1056/NEJMoa0801209 |url=http://dx.doi.org/10.1056/NEJMoa0801209 |accessdate=2012-09-07}}</ref>
*Reweighting of MELD components — MELD formula is getting updated in its weightage being given to coefficients. The updated formula gives lower weightage to serum creatinine and INR and higher to bilirubin.<ref name="pmid18835388">{{cite journal |author=Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS |title=Re-weighting the model for end-stage liver disease score components |journal=[[Gastroenterology]] |volume=135 |issue=5 |pages=1575–81 |year=2008 |month=November |pmid=18835388 |doi=10.1053/j.gastro.2008.08.004 |url=http://linkinghub.elsevier.com/retrieve/pii/S0016-5085(08)01509-6 |accessdate=2012-09-07}}</ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}


==External links==
==External links==
* [http://optn.transplant.hrsa.gov/resources/professionalresources.asp?index=9 Online calculator for MELD score/UNOS modification]
* [http://optn.transplant.hrsa.gov/resources/professionalresources.asp?index=9 Online calculator for MELD score/UNOS modification]
{{WH}}
{{WS}}
[[Category:Hepatology]]
[[Category:Gastroenterology]]

Latest revision as of 17:25, 7 September 2012

WikiDoc Resources for MELD Score

Articles

Most recent articles on MELD Score

Most cited articles on MELD Score

Review articles on MELD Score

Articles on MELD Score in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on MELD Score

Images of MELD Score

Photos of MELD Score

Podcasts & MP3s on MELD Score

Videos on MELD Score

Evidence Based Medicine

Cochrane Collaboration on MELD Score

Bandolier on MELD Score

TRIP on MELD Score

Clinical Trials

Ongoing Trials on MELD Score at Clinical Trials.gov

Trial results on MELD Score

Clinical Trials on MELD Score at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on MELD Score

NICE Guidance on MELD Score

NHS PRODIGY Guidance

FDA on MELD Score

CDC on MELD Score

Books

Books on MELD Score

News

MELD Score in the news

Be alerted to news on MELD Score

News trends on MELD Score

Commentary

Blogs on MELD Score

Definitions

Definitions of MELD Score

Patient Resources / Community

Patient resources on MELD Score

Discussion groups on MELD Score

Patient Handouts on MELD Score

Directions to Hospitals Treating MELD Score

Risk calculators and risk factors for MELD Score

Healthcare Provider Resources

Symptoms of MELD Score

Causes & Risk Factors for MELD Score

Diagnostic studies for MELD Score

Treatment of MELD Score

Continuing Medical Education (CME)

CME Programs on MELD Score

International

MELD Score en Espanol

MELD Score en Francais

Business

MELD Score in the Marketplace

Patents on MELD Score

Experimental / Informatics

List of terms related to MELD Score

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Suvekchha Devkota ; Shankar Kumar, M.B.B.S. [2]]

Overview

The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a disease severity index to help prioritize allocation of organs for transplant. The new system, known as the Model for End-Stage Liver Disease (MELD) score, leaves no room for subjective criteria favoritism or hospital-shopping, as it is based on a mathematical equation. The equation seeks to calculate a patient’s likelihood of dying within three months from their liver disease. In other words under the MELD scoring system - the sickest patient gets the liver transplant. It is more recent than the Child-Pugh score.

Historical Perspective

This model was derived from a heterogeneous group of patients at 4 medical centers in the United States and validated in an independent data set from the Netherlands.[1] The original version of the MELD scale as developed by investigators at Mayo Clinic. It was initially described by Kamath et al in 2001 and modified by Wiesner et al, also in 2001. A number of modification have been made by UNOS (United Network for Organ Sharing) to the model for its implementation in organ allocation for liver transplantation. The Model for End-Stage Liver Disease (MELD) score has been used by the Organ Procurement and Transplantation Network (OPTN) since February 2002 as the basis for allocation of deceased donor livers for transplantation among adults in the United States.[2]

Calculation of MELD Score

The MELD Calculator is a utility that allows you to enter hypothetical or actual parameters and calculate a MELD score for an individual patient. The MELD/PELD Calculator uses the specific formulas approved by the OPTN/UNOS Board of Directors and used for the allocation of livers by the OPTN match system. The MELD score calculation uses-

For candidates on dialysis, defined as having 2 or more dialysis treatments within the prior week; or candidates who have received 24 hours of CVVHD (Continuous Veno-venous Hemodialysis) within the prior week, will have their serum creatinine level automatically set to 4.0 mg/dl. The MELD Calculator is used for candidates who are 12 years and older.

MELD Formula

The MELD (Model for End Stage Liver Disease) is a more objective prognostic score, requiring however a calculation software. [3] The MELD score is calculated using the following formula

  • MELD Score = 0.957 x Loge(creatinine mg/dL) + 0.378 x Loge(bilirubin mg/dL) + 1.120 x Loge(INR)+ 0.6431

Multiply the score by 10 and round to the nearest whole number. Laboratory values less than 1.0 are set to 1.0 for the purposes of the MELD score calculation. or MELD score= 3.8[Ln serum bilirubin (mg/dL)] + 11.2[Ln INR] + 9.6[Ln serum creatinine (mg/dL)] + 6.4 Caveats with the score include:

  • The maximum score given for MELD is 40. All values higher than 40 are given a score of 40
  • If the patient has been dialyzed twice within the last 7 days, then the value for serum creatinine used should be 4.0
  • Any value less than one is given a value of 1 (i.e. if bilirubin is 0.8, a value of 1.0 is used).

Mortality Outcome

In interpreting the MELD Score in hospitalized patients, the 3 month mortality is: [4]

  • 40 or more — 71.3% mortality
  • 30–39 — 52.6% mortality
  • 20–29 — 19.6% mortality
  • 10–19 — 6.0% mortality
  • <9 — 1.9% mortality

The MELD caclulators

A variety of calculators which are specific to a particular clinical scenerio are as follows --

  • The above mentioned UNOS MELD score has laboratory values of INR, total bilirubin and serum creatinine that are <1.0 are set to 1.0. It is used while setting priority for allocating deceased donor organs for liver transplantation.[3]
  • The first MELD score does not use upper or lower limits for laboratory values. Hence, they could have negative values to positive infinity. These are not used for allocation purposes while considering liver transplantation.[4]
  • A MELD score calculator to predict 90-day mortality in patients with alcoholic hepatitis [5]
  • A MELD score calculator for predicting postoperative mortality risk in patients with cirrhosis. This calculator is based upon the first published MELD score, thus the etiology of liver disease is required for the calculation [6]
  • A MELD-Na calculator, which incorporates serum sodium into the model [7]

Comparing Child-Pugh and MELD score

The limitations of Child-Pugh score are as follows-

  • Its based on subjective parameters like ascites and encephalopathy. Not only do these criterias vary with observers but also they may be affected by interventions like diuretics etc.
  • It has a "ceiling and floor" effect. Example- a serum albumin value of 2.8 versus 1.5 will be highly varied clinically but it is rewarded the same point on Child-Pugh.
  • Laboratory to laboratory variations in albumin and prothrombin values.[1]

The points where MELD definitely edges over Child-Pugh score are-

  • It relies on few, readily available, objective variables.
  • Applicable to diverse set of patients with liver disease.
  • Identifies and distinguishes the various points of severity along the disease spectrum.

The points where MELD lags behind are -

Studies have compared the accuracy of MELD versus the Child-Pugh score for predicting the survival of patients on liver transplant waiting list have shown an equivalence but not superiority. [10]The objective criteria used in the MELD score have led to widespread adoption of MELD as an accurate mortality predictor in patients awaiting liver transplantation.

Improving MELD score

The proposed modifications that are on way for MELD score are as follows--

  • MELDNa — Serum sodium levels decrease in cirrhotic patients. One school of thought suggests that in the setting of hyponatremia, it would be advisable to include serum sodium levels in the MELD model. Improvement in accuracy of the MELD score has been noted in studies.[11][12][13][14][15][16]
  • Reweighting of MELD components — MELD formula is getting updated in its weightage being given to coefficients. The updated formula gives lower weightage to serum creatinine and INR and higher to bilirubin.[17]

References

  1. ↑ 1.0 1.1 Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL; et al. (2001). "A model to predict survival in patients with end-stage liver disease". Hepatology. 33 (2): 464–70. doi:10.1053/jhep.2001.22172. PMID 11172350.
  2. ↑ Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ (2008). "Disparities in liver transplantation before and after introduction of the MELD score". JAMA. 300 (20): 2371–8. doi:10.1001/jama.2008.720. PMID 19033587.
  3. ↑ Gex L, Bernard C, Spahr L (2010). "[Child-Pugh, MELD and Maddrey scores]". Rev Med Suisse (in French). 6 (264): 1803–4, 1806–8. PMID 20964016. Unknown parameter |month= ignored (help)
  4. ↑ Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P; et al. (2003). "Model for end-stage liver disease (MELD) and allocation of donor livers". Gastroenterology. 124 (1): 91–6. doi:10.1053/gast.2003.50016. PMID 12512033.
  5. ↑ Trotter JF, Brimhall B, Arjal R, Phillips C (2004). "Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation". Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 10 (8): 995–1000. doi:10.1002/lt.20195. PMID 15390325. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  6. ↑ Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'Era A, Sei C, Mannucci PM (2007). "The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation". Hepatology (Baltimore, Md.). 46 (2): 520–7. doi:10.1002/hep.21732. PMID 17659574. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  7. ↑ Bellest L, Eschwège V, Poupon R, Chazouillères O, Robert A (2007). "A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology". Hepatology (Baltimore, Md.). 46 (2): 528–34. doi:10.1002/hep.21680. PMID 17654598. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  8. ↑ Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK (2007). "Different methods of creatinine measurement significantly affect MELD scores". Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 13 (4): 523–9. doi:10.1002/lt.20994. PMID 17323365. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  9. ↑ Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L (2005). <297:CMSOTA>2.0.CO;2 "Creatinine measurement: state of the art in accuracy and interlaboratory harmonization". Archives of Pathology & Laboratory Medicine. 129 (3): 297–304. doi:10.1043/1543-2165(2005)129<297:CMSOTA>2.0.CO;2. PMID 15737021. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  10. ↑ Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK (2006). "A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation". Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 12 (7): 1049–61. doi:10.1002/lt.20824. PMID 16799946. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  11. ↑ Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G (2006). "Evidence-based incorporation of serum sodium concentration into MELD". Gastroenterology. 130 (6): 1652–60. doi:10.1053/j.gastro.2006.02.010. PMID 16697729. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  12. ↑ Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P (2007). "MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation". Gut. 56 (9): 1283–90. doi:10.1136/gut.2006.102764. PMC 1954951. PMID 17452425. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  13. ↑ Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J (2007). "An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis". Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 13 (8): 1174–80. doi:10.1002/lt.21197. PMID 17663415. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  14. ↑ Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA (2004). "Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death". Hepatology (Baltimore, Md.). 40 (4): 802–10. doi:10.1002/hep.20405. PMID 15382176. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  15. ↑ Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005). "Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone". Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 11 (3): 336–43. doi:10.1002/lt.20329. PMID 15719386. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  16. ↑ Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM (2008). "Hyponatremia and mortality among patients on the liver-transplant waiting list". The New England Journal of Medicine. 359 (10): 1018–26. doi:10.1056/NEJMoa0801209. PMID 18768945. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)
  17. ↑ Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS (2008). "Re-weighting the model for end-stage liver disease score components". Gastroenterology. 135 (5): 1575–81. doi:10.1053/j.gastro.2008.08.004. PMID 18835388. Retrieved 2012-09-07. Unknown parameter |month= ignored (help)

External links

Template:WH

Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=MELD_Score&oldid=729438"